Wednesday, December 31, 2014

Company announcements: Ziwo, Miyoshi^, Star Pharm, Zagro Asia

Ziwo - General Announcement::Resignation of Independent Director

Announcement Type: General Announcement
Company: ZIWO HOLDINGS LTD.
Stock Code/Name: I9T - Ziwo

General Announcement::Resignation of Independent Director
Issuer & Securities
Issuer/ ManagerZIWO HOLDINGS LTD.
SecuritiesZIWO HOLDINGS LTD. - SG1Y74948866 - I9T
Stapled SecurityNo
Announcement Details
Announcement Title General Announcement
Date & Time of Broadcast31-Dec-2014 17:14:02
StatusNew
Announcement Sub TitleResignation of Independent Director
Announcement ReferenceSG141231OTHR0U10
Submitted By (Co./ Ind. Name)Ting Chun Yuen
DesignationExecutive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)Please refer to the attachment.
Attachments



Ziwo - Change - Announcement of Cessation::Announcement of Cessation as Non-Executive Director

Announcement Type: Announcement of Cessation
Company: ZIWO HOLDINGS LTD.
Stock Code/Name: I9T - Ziwo

Change - Announcement of Cessation::Announcement of Cessation as Non-Executive Director
Issuer & Securities
Issuer/ ManagerZIWO HOLDINGS LTD.
SecuritiesZIWO HOLDINGS LTD. - SG1Y74948866 - I9T
Stapled SecurityNo
Announcement Details
Announcement Title Change - Announcement of Cessation
Date & Time of Broadcast31-Dec-2014 17:12:54
StatusNew
Announcement Sub TitleAnnouncement of Cessation as Non-Executive Director
Announcement ReferenceSG141231OTHR80SY
Submitted By (Co./ Ind. Name)Ting Chun Yuen
DesignationExecutive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)Announcement of Cessation as Non-Executive Director
Additional Details
Name Of PersonWong Chee Meng Lawrence
Age47
Is effective date of cessation known?Yes
If yes, please provide the date31/12/2014
Detailed Reason (s) for cessationTo pursue his other commitments.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?No
Any other relevant information to be provided to shareholders of the listed issuer?No
Date of Appointment to current position29/04/2011
Does the AC have a minimum of 3 members (taking into account this cessation)?No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)Independent Director, Chairman of Remuneration Committee and a member of Audit Committee and Nominating Committee
Role and responsibilitiesIndependent and Non-Executive
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiariesNil.
Shareholding interest in the listed issuer and its subsidiaries?No
Past (for the last 5 years)WE Holdings Ltd., Harry's Holdings Pte. Ltd., Juken Technology Limited, SG Tech Holdings Limited
PresentChina Bearing (Singapore) Ltd., Artivision Technologies Limited,
Sino Grandness Food Industry Group Limited, Equity Law LLC, EQ Advisory Pte. Ltd. EQ Compliance Pte. Ltd.



Miyoshi^ - General Announcement::Change of Company's Name to Miyoshi Limited

Announcement Type: General Announcement
Company: MIYOSHI PRECISION LIMITED
Stock Code/Name: M03 - Miyoshi^

General Announcement::Change of Company's Name to Miyoshi Limited
Issuer & Securities
Issuer/ ManagerMIYOSHI PRECISION LIMITED
SecuritiesMIYOSHI PRECISION LIMITED - SG1J04885492 - M03
Stapled SecurityNo
Announcement Details
Announcement Title General Announcement
Date & Time of Broadcast31-Dec-2014 17:00:01
StatusNew
Announcement Sub TitleChange of Company's Name to Miyoshi Limited
Announcement ReferenceSG141231OTHR6I11
Submitted By (Co./ Ind. Name)Sin Kwong Wah Andrew
DesignationCEO
Description (Please provide a detailed description of the event in the box below)The Board of Directors (the Board) of Miyoshi Precision Limited (the Company) is pleased to announce that pursuant to the resolution passed at the Extraordinary General Meeting of the Company held on 29 December 2014, the special resolution relating to the proposed change of Company's name from Miyoshi Precision Limited to Miyoshi Limited has been lodged with the Accounting and Corporate Regulatory Authority of Singapore (ACRA). ACRA has notified that, with effect from 31 December 2014, the Company shall be known as Miyoshi Limited.
Attachments



Star Pharm - Change - Announcement of Appointment::Appointment of Independent Director Who Is An Audit Committee Member

Announcement Type: Announcement of Appointment
Company: STAR PHARMACEUTICAL LIMITED
Stock Code/Name: X64 - Star Pharm

Change - Announcement of Appointment::Appointment of Independent Director Who Is An Audit Committee Member
Issuer & Securities
Issuer/ ManagerSTAR PHARMACEUTICAL LIMITED
SecuritiesSTAR PHARMACEUTICAL LIMITED - SG1S90928817 - X64
Stapled SecurityNo
Announcement Details
Announcement Title Change - Announcement of Appointment
Date & Time of Broadcast31-Dec-2014 15:46:56
StatusNew
Announcement Sub TitleAppointment of Independent Director Who Is An Audit Committee Member
Announcement ReferenceSG141231OTHRRYQ5
Submitted By (Co./ Ind. Name)Xu Zhi Bin
DesignationExecutive Chairman
Description (Please provide a detailed description of the event in the box below)Appointment of Independent Director Who Is An Audit Committee Member
Additional Details
Date Of Appointment01/01/2015
Name Of PersonMeng Tao
Age45
Country Of Principal ResidenceChina
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)The nomination of Mr. Meng Tao ("Mr. Meng") as an Independent Director was duly reviewed by the Company's Nominating Committee and Board of Directors (the "Board"). The Board is of the view that Mr. Meng's experience will enhance the core competencies of the Board.
Whether appointment is executive, and if so, the area of responsibilityNon-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)Independent Director, Chairman of the Nominating Committee and member of the Audit Committee and Remuneration Committee
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiariesNil
Conflict of interests (including any competing business)Nil
Working experience and occupation(s) during the past 10 yearsNovember 2013 to present International Trade Consultant of Beijing Jiashi Hongrun Phar Co., Ltd

September 2003 to October 2013 International Trade Consultant of Haerbin Medisan Pharmaceutical Co., Ltd
Shareholding interest in the listed issuer and its subsidiaries?No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)Nil
PresentNil
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?No
(c) Whether there is any unsatisfied judgment against him?No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?No
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; orNo
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; orNo
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; orNo
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?No
Any prior experience as a director of a listed company?No
If No, Please provide details of any training undertaken in the roles and responsibilities of a director of a listed companyMr. Meng will attend the required training / courses to familiarize himself with the roles and responsibilities of a director of a listed
company in Singapore.



Zagro Asia - Asset Acquisitions and Disposals::INCREASED INVESTMENT IN WHOLLY-OWNED SUBSIDIARY

Announcement Type: Asset Acquisitions and Disposals
Company: ZAGRO ASIA LIMITED
Stock Code/Name: Z01 - Zagro Asia

Asset Acquisitions and Disposals::INCREASED INVESTMENT IN WHOLLY-OWNED SUBSIDIARY
Issuer & Securities
Issuer/ ManagerZAGRO ASIA LIMITED
SecuritiesZAGRO ASIA LIMITED - SG1C95016004 - Z01
Stapled SecurityNo
Announcement Details
Announcement Title Asset Acquisitions and Disposals
Date & Time of Broadcast31-Dec-2014 15:50:39
StatusNew
Announcement Sub TitleINCREASED INVESTMENT IN WHOLLY-OWNED SUBSIDIARY
Announcement ReferenceSG141231OTHRBZKK
Submitted By (Co./ Ind. Name)POH BENG SWEE
DesignationCHAIRMAN
Description (Please provide a detailed description of the event in the box below)Please refer to the attachment.
Attachments



No comments:

Post a Comment